Average Co-Inventor Count = 4.03
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Exelixis, Inc. (5 from 173 patents)
5 patents:
1. 12016854 - Liquid dosage forms to treat cancer
2. 11504362 - Liquid dosage forms to treat cancer
3. 11141413 - Method of treating renal cell carcinoma using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, (2S)-hydroxybutanedioate
4. 10273211 - Metabolites of N-{4-([6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
5. 10159666 - Dosing of cabozantinib formulations